Cardiff Oncology Inc. (NASDAQ: CRDF) Stock Information | RedChip

Cardiff Oncology Inc. (NASDAQ: CRDF)


$4.2000
-0.0600 ( -4.33% ) 436.3K

Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").

Market Data


Open


$4.2000

Previous close


$4.2600

Volume


436.3K

Market cap


$278.07M

Day range


$4.1440 - $4.5240

52 week range


$1.4100 - $6.4200

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
8-k 8K-related 14 Jun 20, 2024
8-k 8K-related 15 Jun 03, 2024
10-q Quarterly Reports 48 May 02, 2024
8-k 8K-related 16 May 02, 2024
def Proxies and info statements 15 Apr 25, 2024

Latest News